Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kidney metastases

C M Dresler1

  • 1Section of Thoracic Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

Chest Surgery Clinics of North America
|March 27, 1998
PubMed
Summary
This summary is machine-generated.

Renal cell carcinoma (RCC) is a challenging cancer to cure, with surgery being the most effective treatment. Further research is essential to identify reliable indicators for surgical success in RCC patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic.

The European respiratory journal·2009
Same author

Metabolic gene polymorphism frequencies in control populations.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Same author

Smoking, smoking cessation and the oncologist.

Lung cancer (Amsterdam, Netherlands)·2001
Same author

Gender differences in genetic susceptibility for lung cancer.

Lung cancer (Amsterdam, Netherlands)·2001
Same author

Systemic distribution of talc.

Chest·1999
Same author

Prognostic value of positive pleural lavage in patients with lung cancer resection.

The Annals of thoracic surgery·1999
Same journal

New treatment modalities for end-stage emphysema.

Chest surgery clinics of North America·2003
Same journal

Cost effectiveness of lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Results of lung volume reduction surgery for emphysema.

Chest surgery clinics of North America·2003
Same journal

Complications after lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Operative techniques for lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Patient selection for lung volume reduction surgery.

Chest surgery clinics of North America·2003
See all related articles

Area of Science:

  • Oncology
  • Surgical Oncology
  • Urologic Oncology

Background:

  • Renal cell carcinoma (RCC) represents a relatively uncommon malignancy.
  • Despite advancements, curative treatment for RCC remains difficult, with limited progress in chemotherapy and immunotherapy.
  • Surgery is currently the most successful curative treatment modality for both primary and metastatic RCC.

Purpose of the Study:

  • To highlight the critical need for prospective studies in renal cell carcinoma.
  • To emphasize the importance of identifying definitive prognostic indicators for surgical intervention in RCC.
  • To underscore the current limitations in non-surgical treatment efficacy for RCC.

Main Methods:

  • This study is a review and analysis of current treatment paradigms for renal cell carcinoma.

Related Experiment Videos

  • Focuses on evaluating the efficacy of surgical interventions versus other therapeutic approaches.
  • Highlights the necessity for prospective clinical trials to establish prognostic factors.

    • Main Results:

    • Surgery demonstrates the highest success rate for curative treatment in both primary and metastatic renal cell carcinoma.
    • Chemotherapy and immunotherapy have shown minimal improvements in overall cure rates for RCC.
    • There is a significant lack of robust data regarding prognostic indicators for surgical outcomes in RCC.

    Conclusions:

    • Surgical intervention remains the cornerstone of curative therapy for renal cell carcinoma.
    • Further prospective research is imperative to establish reliable prognostic indicators for optimizing surgical outcomes in RCC patients.
    • Enhanced understanding of prognostic factors will guide clinical decision-making and improve patient management in RCC.